P774: CLINICAL OUTCOMES ASSOCIATED WITH AZACITIDINE MONOTHERAPY FOR TREATMENT-NAIVE PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME (HR MDS): A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS

• K. Hasegawa,
• A. H. Wei,
• G. Garcia-Manero,
• N. G. Daver,
• N. Rajakumaraswamy,
• S. Iqbal,
• R. J. Chan,
• H. Hu,
• P. Tse,
• J. Yan,
• M. J. Zoratti,
• F. Xie,
• D. A. Sallman

Affiliations

K. Hasegawa

1 Gilead Sciences, Inc., Foster City, United States of America

A. H. Wei

2 Department of Clinical Haematology, The Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia

G. Garcia-Manero

3 The University of Texas MD Anderson Cancer Center, Houston, United States of America

N. G. Daver

3 The University of Texas MD Anderson Cancer Center, Houston, United States of America

N. Rajakumaraswamy

1 Gilead Sciences, Inc., Foster City, United States of America

S. Iqbal

1 Gilead Sciences, Inc., Foster City, United States of America

R. J. Chan

1 Gilead Sciences, Inc., Foster City, United States of America

H. Hu

1 Gilead Sciences, Inc., Foster City, United States of America

P. Tse

4 McMaster University, Hamilton, Canada

J. Yan

4 McMaster University, Hamilton, Canada

M. J. Zoratti

4 McMaster University, Hamilton, Canada

F. Xie

4 McMaster University, Hamilton, Canada

D. A. Sallman

5 Moffitt Cancer Center, Tampa, United States of America